Longevity Patent Family

PHARMACEUTICAL COMPOSITIONS COMPRISING ERTUGLIFLOZIN AND METFORMIN

Source-linked patent metadata for PHARMACEUTICAL COMPOSITIONS COMPRISING ERTUGLIFLOZIN AND METFORMIN, including priority, record stage and longevity-topic connections.

Patent-family snapshot

Application publication visible

Family grouping brings related publications for the same invention together, instead of counting every national filing as a separate technology.

Representative publication
WO2026206274A1
Earliest priority
March 28, 2025
Latest publication
October 1, 2026
Family publications
1
Patent offices
1
Patent-to-Evidence Translation Map

What is happening in the same scientific field?

These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.

Organizations

Organizations named in this family

HUMANIS SAĞLIK A.Ş.ApplicantHUMANIS SAGLIK A S [TR]Applicant
Longevity context

Topics connected by metadata

Metformin88% metadata match
Knowledge connections

What this family cites

Earlier patent references
0
Scientific and other non-patent references
0
Priority dates represented
1

References show which earlier documents the patent record points to. They do not validate the invention or prove that cited research supports its claims.

Technical classification

How the patent office classifies this invention

No patent classification is available in the retained record.

Verify in the original patent source →